We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-2.46%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$392B
AUM Growth
-$22.8B
Cap. Flow
-$849M
Cap. Flow %
-0.22%
Top 10 Hldgs %
11.81%
Holding
4,189
New
137
Increased
2,071
Reduced
1,612
Closed
191

Top Buys

Rank Stock Value
1
HEI.A icon
HEICO Corp Class A
HEI.A
+$873M
2
FERG icon
Ferguson
FERG
+$750M
3
UNH icon
UnitedHealth
UNH
+$641M
4
AAPL icon
Apple
AAPL
+$619M
5
V icon
Visa
V
+$612M

Sector Composition

Rank Sector Weight
1 Technology 19.91%
2 Financials 13.06%
3 Healthcare 12.67%
4 Consumer Discretionary 10.55%
5 Industrials 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIPO icon
3826
Hippo Holdings
HIPO
$777M
$41K ﹤0.01%
822
-143
-15% -$7.39K
ATHX
3827
DELISTED
Athersys, Inc. Common Stock
ATHX
$41K ﹤0.01%
2,694
-60
-2% -$1.25K
NAGE
3828
Niagen Bioscience
NAGE
$256M
$39K ﹤0.01%
15,789
-390
-2% -$1.07K
EVLO
3829
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$39K ﹤0.01%
577
+8
+1% +$666
RNAC icon
3830
Cartesian Therapeutics
RNAC
$218M
$37K ﹤0.01%
999
+59
+6% +$3.69K
MBII
3831
DELISTED
Marrone Bio Innovations, Inc.
MBII
$37K ﹤0.01%
33,949
-791
-2% -$597
FBIO icon
3832
Fortress Biotech
FBIO
$111M
$35K ﹤0.01%
1,731
+56
+3% +$1.53K
INFI
3833
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$35K ﹤0.01%
31,078
-58
-0.2% -$69
PBYI icon
3834
Puma Biotechnology
PBYI
$398M
$34K ﹤0.01%
11,855
+35
+0.3% +$91
WVE icon
3835
Wave Life Sciences
WVE
$1.12B
$34K ﹤0.01%
16,735
+1,695
+11% +$4.15K
DNTH icon
3836
Dianthus Therapeutics
DNTH
$5.69B
$33K ﹤0.01%
708
+14
+2% +$765
ARDX icon
3837
Ardelyx
ARDX
$1.24B
$32K ﹤0.01%
29,902
-287
-1% -$256
IMDX
3838
Insight Molecular Diagnostics
IMDX
$141M
$32K ﹤0.01%
1,083
+13
+1% +$416
PAVM icon
3839
PAVmed
PAVM
$36.5M
$32K ﹤0.01%
54
-1
-2% -$743
TNXP icon
3840
Tonix Pharmaceuticals
TNXP
$152M
0
QTNT
3841
DELISTED
Quotient Limited Ordinary Shares
QTNT
$32K ﹤0.01%
661
-16
-2% -$956
SURF
3842
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$31K ﹤0.01%
10,736
+129
+1% +$452
AMPE
3843
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$31K ﹤0.01%
219
-5
-2% -$730
AQB icon
3844
AquaBounty Technologies
AQB
$4.73M
$29K ﹤0.01%
780
-15
-2% -$522
SYRE icon
3845
Spyre Therapeutics
SYRE
$8.5B
$29K ﹤0.01%
494
+6
+1% +$504
AWH
3846
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$29K ﹤0.01%
1,939
-37
-2% -$641
GOCO
3847
DELISTED
GoHealth
GOCO
$28K ﹤0.01%
1,562
-7,617
-83% -$237K
SMMT icon
3848
Summit Therapeutics
SMMT
$10.2B
$28K ﹤0.01%
11,273
+584
+5% +$1.47K
SEEL
3849
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$28K ﹤0.01%
9
TRVN
3850
DELISTED
Trevena, Inc.
TRVN
$27K ﹤0.01%
78
-1
-1% -$315

Similar funds

Invesco's Q1 2022 Portfolio in Review

As of Q1 2022, Invesco held 4,189 positions worth $392B, down 5.5% from $415B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Invesco's Q1 2022 filing shows 137 new, 2,071 increased, 1,612 reduced and 191 closed positions. Its largest new stake was Ferguson: 4,859,882 shares worth $652M. The largest sale was Vale, an estimated $814M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Invesco's largest Q1 2022 buy was Ferguson: 4,859,882 shares worth $652M.
  • Invesco added most to HEICO Corp Class A in Q1 2022, an estimated $873M increase.
  • Invesco's biggest Q1 2022 reduction was Vale, cutting an estimated $814M.
  • Invesco fully exited Xilinx Inc in Q1 2022, selling an estimated $200M.
  • Invesco's ten largest holdings make up 12% of its $392B portfolio in Q1 2022.
  • Invesco opened 137 new positions and closed 191 in Q1 2022.
  • Invesco's portfolio value fell 5.5% quarter-over-quarter to $392B.

Based on Invesco's 13F filing for Q1 2022, filed 16 May 2022.